• +1 513 549 5911 (U.S.)
  • +44 203 318 2846 (U.K.)

30 mins free consultation for each report        Upto 50% Discounts for Highest selling reports

Biologics and Biosimilars Market

Global Biologics and Biosimilars Market by Manufacturers, Regions, Type and Application, Forecast to 2023


A biologic is a medicine made using a living system, and historically this was often an animal. Most products being developed as biosimilars are recombinant proteins, or proteins derived from genetically engineered DNA. In this report is a biologic defined as proteins, peptides, hormones or antibodies drugs production by bio-engineered technology, but does not include a vaccine.

Scope of the Report:
This report focuses on the Biologics and Biosimilars in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Most of biologics manufacturer are concentrated in US, Germany,UK and other developed countries. But in biosimilars industry the situation is different, manufacturer in developing countries play a very important role.
Through the research we tend to believe that the growth of biologics industry maybe slow but high profits during the period of patent may attractive. As to biosimilars, now is a changce for newcomers and they will greatly change the industry.

The worldwide market for Biologics and Biosimilars is expected to grow at a CAGR of roughly 5.5% over the next five years, will reach 199600 million US$ in 2023, from 144700 million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers
    Roche
    Amgen
    AbbVie
    Sanofi-Aventis
    Johnson & Johnson
    Pfizer
    Novo Nordisk
    Eli Lilly
    Novartis
    Merck
    3sbio
    Changchun High Tech
    CP Guojian
    Biotech
    Gelgen
    Innovent
    Dong Bao
    Ganlee
    United Laboratories
    Others

Market Segment by Regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia and Italy)
    Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
    South America (Brazil, Argentina, Colombia etc.)
    Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
    Antibody
    Hormone
    Growth Factors
    Other

Market Segment by Applications, can be divided into
    Tumor
    Diabetes
    Cardiovascular
    Hemophilia
    Other

There are 15 Chapters to deeply display the global Biologics and Biosimilars market.
Chapter 1, to describe Biologics and Biosimilars Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Biologics and Biosimilars, with sales, revenue, and price of Biologics and Biosimilars, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Biologics and Biosimilars, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Biologics and Biosimilars market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Biologics and Biosimilars sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source	
Table of Contents

1 Market Overview
    1.1 Biologics and Biosimilars Introduction
    1.2 Market Analysis by Type
        1.2.1 Antibody
        1.2.2 Hormone
        1.2.3 Growth Factors
        1.2.4 Other
    1.3 Market Analysis by Applications
        1.3.1 Tumor
        1.3.2 Diabetes
        1.3.3 Cardiovascular
        1.3.4 Hemophilia
        1.3.5 Other
    1.4 Market Analysis by Regions
        1.4.1 North America (United States, Canada and Mexico)
            1.4.1.1 United States Market States and Outlook (2013-2023)
            1.4.1.2 Canada Market States and Outlook (2013-2023)
            1.4.1.3 Mexico Market States and Outlook (2013-2023)
        1.4.2 Europe (Germany, France, UK, Russia and Italy)
            1.4.2.1 Germany Market States and Outlook (2013-2023)
            1.4.2.2 France Market States and Outlook (2013-2023)
            1.4.2.3 UK Market States and Outlook (2013-2023)
            1.4.2.4 Russia Market States and Outlook (2013-2023)
            1.4.2.5 Italy Market States and Outlook (2013-2023)
        1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
            1.4.3.1 China Market States and Outlook (2013-2023)
            1.4.3.2 Japan Market States and Outlook (2013-2023)
            1.4.3.3 Korea Market States and Outlook (2013-2023)
            1.4.3.4 India Market States and Outlook (2013-2023)
            1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
        1.4.4 South America, Middle East and Africa
            1.4.4.1 Brazil Market States and Outlook (2013-2023)
            1.4.4.2 Egypt Market States and Outlook (2013-2023)
            1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
            1.4.4.4 South Africa Market States and Outlook (2013-2023)
            1.4.4.5 Nigeria Market States and Outlook (2013-2023)
    1.5 Market Dynamics
        1.5.1 Market Opportunities
        1.5.2 Market Risk
        1.5.3 Market Driving Force
2 Manufacturers Profiles
    2.1 Roche
        2.1.1 Business Overview
        2.1.2 Biologics and Biosimilars Type and Applications
            2.1.2.1 Product A
            2.1.2.2 Product B
        2.1.3 Roche Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.2 Amgen
        2.2.1 Business Overview
        2.2.2 Biologics and Biosimilars Type and Applications
            2.2.2.1 Product A
            2.2.2.2 Product B
        2.2.3 Amgen Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.3 AbbVie
        2.3.1 Business Overview
        2.3.2 Biologics and Biosimilars Type and Applications
            2.3.2.1 Product A
            2.3.2.2 Product B
        2.3.3 AbbVie Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.4 Sanofi-Aventis
        2.4.1 Business Overview
        2.4.2 Biologics and Biosimilars Type and Applications
            2.4.2.1 Product A
            2.4.2.2 Product B
        2.4.3 Sanofi-Aventis Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.5 Johnson & Johnson
        2.5.1 Business Overview
        2.5.2 Biologics and Biosimilars Type and Applications
            2.5.2.1 Product A
            2.5.2.2 Product B
        2.5.3 Johnson & Johnson Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.6 Pfizer
        2.6.1 Business Overview
        2.6.2 Biologics and Biosimilars Type and Applications
            2.6.2.1 Product A
            2.6.2.2 Product B
        2.6.3 Pfizer Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.7 Novo Nordisk
        2.7.1 Business Overview
        2.7.2 Biologics and Biosimilars Type and Applications
            2.7.2.1 Product A
            2.7.2.2 Product B
        2.7.3 Novo Nordisk Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.8 Eli Lilly
        2.8.1 Business Overview
        2.8.2 Biologics and Biosimilars Type and Applications
            2.8.2.1 Product A
            2.8.2.2 Product B
        2.8.3 Eli Lilly Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.9 Novartis
        2.9.1 Business Overview
        2.9.2 Biologics and Biosimilars Type and Applications
            2.9.2.1 Product A
            2.9.2.2 Product B
        2.9.3 Novartis Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.10 Merck
        2.10.1 Business Overview
        2.10.2 Biologics and Biosimilars Type and Applications
            2.10.2.1 Product A
            2.10.2.2 Product B
        2.10.3 Merck Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.11 3sbio
        2.11.1 Business Overview
        2.11.2 Biologics and Biosimilars Type and Applications
            2.11.2.1 Product A
            2.11.2.2 Product B
        2.11.3 3sbio Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.12 Changchun High Tech
        2.12.1 Business Overview
        2.12.2 Biologics and Biosimilars Type and Applications
            2.12.2.1 Product A
            2.12.2.2 Product B
        2.12.3 Changchun High Tech Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.13 CP Guojian
        2.13.1 Business Overview
        2.13.2 Biologics and Biosimilars Type and Applications
            2.13.2.1 Product A
            2.13.2.2 Product B
        2.13.3 CP Guojian Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.14 Biotech
        2.14.1 Business Overview
        2.14.2 Biologics and Biosimilars Type and Applications
            2.14.2.1 Product A
            2.14.2.2 Product B
        2.14.3 Biotech Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.15 Gelgen
        2.15.1 Business Overview
        2.15.2 Biologics and Biosimilars Type and Applications
            2.15.2.1 Product A
            2.15.2.2 Product B
        2.15.3 Gelgen Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.16 Innovent
        2.16.1 Business Overview
        2.16.2 Biologics and Biosimilars Type and Applications
            2.16.2.1 Product A
            2.16.2.2 Product B
        2.16.3 Innovent Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.17 Dong Bao
        2.17.1 Business Overview
        2.17.2 Biologics and Biosimilars Type and Applications
            2.17.2.1 Product A
            2.17.2.2 Product B
        2.17.3 Dong Bao Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.18 Ganlee
        2.18.1 Business Overview
        2.18.2 Biologics and Biosimilars Type and Applications
            2.18.2.1 Product A
            2.18.2.2 Product B
        2.18.3 Ganlee Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.19 United Laboratories
        2.19.1 Business Overview
        2.19.2 Biologics and Biosimilars Type and Applications
            2.19.2.1 Product A
            2.19.2.2 Product B
        2.19.3 United Laboratories Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
    2.20 Others
        2.20.1 Business Overview
        2.20.2 Biologics and Biosimilars Type and Applications
            2.20.2.1 Product A
            2.20.2.2 Product B
        2.20.3 Others Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Biologics and Biosimilars Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
    3.1 Global Biologics and Biosimilars Sales and Market Share by Manufacturer (2016-2017)
    3.2 Global Biologics and Biosimilars Revenue and Market Share by Manufacturer (2016-2017)
    3.3 Market Concentration Rate
        3.3.1 Top 3 Biologics and Biosimilars Manufacturer Market Share in 2017
        3.3.2 Top 6 Biologics and Biosimilars Manufacturer Market Share in 2017
    3.4 Market Competition Trend
4 Global Biologics and Biosimilars Market Analysis by Regions
    4.1 Global Biologics and Biosimilars Sales, Revenue and Market Share by Regions
        4.1.1 Global Biologics and Biosimilars Sales and Market Share by Regions (2013-2018)
        4.1.2 Global Biologics and Biosimilars Revenue and Market Share by Regions (2013-2018)
    4.2 North America Biologics and Biosimilars  Sales and Growth Rate (2013-2018)
    4.3 Europe Biologics and Biosimilars  Sales and Growth Rate (2013-2018)
    4.4 Asia-Pacific Biologics and Biosimilars  Sales and Growth Rate (2013-2018)
    4.5 South America Biologics and Biosimilars  Sales and Growth Rate (2013-2018)
    4.6 Middle East and Africa Biologics and Biosimilars  Sales and Growth Rate (2013-2018)
5 North America Biologics and Biosimilars by Countries
    5.1 North America Biologics and Biosimilars Sales, Revenue and Market Share by Countries
        5.1.1 North America Biologics and Biosimilars Sales and Market Share by Countries (2013-2018)
        5.1.2 North America Biologics and Biosimilars Revenue and Market Share by Countries (2013-2018)
    5.2 United States Biologics and Biosimilars Sales and Growth Rate (2013-2018)
    5.3 Canada Biologics and Biosimilars Sales and Growth Rate (2013-2018)
    5.4 Mexico Biologics and Biosimilars Sales and Growth Rate (2013-2018)
6 Europe Biologics and Biosimilars by Countries
    6.1 Europe Biologics and Biosimilars Sales, Revenue and Market Share by Countries
        6.1.1 Europe Biologics and Biosimilars Sales and Market Share by Countries (2013-2018)
        6.1.2 Europe Biologics and Biosimilars Revenue and Market Share by Countries (2013-2018)
    6.2 Germany Biologics and Biosimilars Sales and Growth Rate (2013-2018)
    6.3 UK Biologics and Biosimilars Sales and Growth Rate (2013-2018)
    6.4 France Biologics and Biosimilars Sales and Growth Rate (2013-2018)
    6.5 Russia Biologics and Biosimilars Sales and Growth Rate (2013-2018)
    6.6 Italy Biologics and Biosimilars Sales and Growth Rate (2013-2018)
7 Asia-Pacific Biologics and Biosimilars by Countries
    7.1 Asia-Pacific Biologics and Biosimilars Sales, Revenue and Market Share by Countries
        7.1.1 Asia-Pacific Biologics and Biosimilars Sales and Market Share by Countries (2013-2018)
        7.1.2 Asia-Pacific Biologics and Biosimilars Revenue and Market Share by Countries (2013-2018)
    7.2 China Biologics and Biosimilars Sales and Growth Rate (2013-2018)
    7.3 Japan Biologics and Biosimilars Sales and Growth Rate (2013-2018)
    7.4 Korea Biologics and Biosimilars Sales and Growth Rate (2013-2018)
    7.5 India Biologics and Biosimilars Sales and Growth Rate (2013-2018)
    7.6 Southeast Asia Biologics and Biosimilars Sales and Growth Rate (2013-2018)
8 South America Biologics and Biosimilars by Countries
    8.1 South America Biologics and Biosimilars Sales, Revenue and Market Share by Countries
        8.1.1 South America Biologics and Biosimilars Sales and Market Share by Countries (2013-2018)
        8.1.2 South America Biologics and Biosimilars Revenue and Market Share by Countries (2013-2018)
    8.2 Brazil Biologics and Biosimilars Sales and Growth Rate (2013-2018)
    8.3 Argentina Biologics and Biosimilars Sales and Growth Rate (2013-2018)
    8.4 Colombia Biologics and Biosimilars Sales and Growth Rate (2013-2018)
9 Middle East and Africa Biologics and Biosimilars by Countries
    9.1 Middle East and Africa Biologics and Biosimilars Sales, Revenue and Market Share by Countries
        9.1.1 Middle East and Africa Biologics and Biosimilars Sales and Market Share by Countries (2013-2018)
        9.1.2 Middle East and Africa Biologics and Biosimilars Revenue and Market Share by Countries (2013-2018)
    9.2 Saudi Arabia Biologics and Biosimilars Sales and Growth Rate (2013-2018)
    9.3 UAE Biologics and Biosimilars Sales and Growth Rate (2013-2018)
    9.4 Egypt Biologics and Biosimilars Sales and Growth Rate (2013-2018)
    9.5 Nigeria Biologics and Biosimilars Sales and Growth Rate (2013-2018)
    9.6 South Africa Biologics and Biosimilars Sales and Growth Rate (2013-2018)
10 Global Biologics and Biosimilars Market Segment by Type
    10.1 Global Biologics and Biosimilars Sales, Revenue and Market Share by Type (2013-2018)
        10.1.1 Global Biologics and Biosimilars Sales and Market Share by Type (2013-2018)
        10.1.2 Global Biologics and Biosimilars Revenue and Market Share by Type (2013-2018)
    10.2 Antibody Sales Growth and Price
        10.2.1 Global Antibody Sales Growth (2013-2018)
        10.2.2 Global Antibody Price (2013-2018)
    10.3 Hormone Sales Growth and Price
        10.3.1 Global Hormone Sales Growth (2013-2018)
        10.3.2 Global Hormone Price (2013-2018)
    10.4 Growth Factors Sales Growth and Price
        10.4.1 Global Growth Factors Sales Growth (2013-2018)
        10.4.2 Global Growth Factors Price (2013-2018)
    10.5 Other Sales Growth and Price
        10.5.1 Global Other Sales Growth (2013-2018)
        10.5.2 Global Other Price (2013-2018)
11 Global Biologics and Biosimilars Market Segment by Application
    11.1 Global Biologics and Biosimilars Sales Market Share by Application (2013-2018)
    11.2 Tumor Sales Growth (2013-2018)
    11.3 Diabetes Sales Growth (2013-2018)
    11.4 Cardiovascular Sales Growth (2013-2018)
    11.5 Hemophilia Sales Growth (2013-2018)
    11.6 Other Sales Growth (2013-2018)
12 Biologics and Biosimilars Market Forecast (2018-2023)
    12.1 Global Biologics and Biosimilars Sales, Revenue and Growth Rate (2018-2023)
    12.2 Biologics and Biosimilars Market Forecast by Regions (2018-2023)
        12.2.1 North America Biologics and Biosimilars Market Forecast (2018-2023)
        12.2.2 Europe Biologics and Biosimilars Market Forecast (2018-2023)
        12.2.3 Asia-Pacific Biologics and Biosimilars Market Forecast (2018-2023)
        12.2.4 South America Biologics and Biosimilars Market Forecast (2018-2023)
        12.2.5 Middle East and Africa Biologics and Biosimilars Market Forecast (2018-2023)
    12.3 Biologics and Biosimilars Market Forecast by Type (2018-2023)
        12.3.1 Global Biologics and Biosimilars Sales Forecast by Type (2018-2023)
        12.3.2 Global Biologics and Biosimilars Market Share Forecast by Type (2018-2023)
    12.4 Biologics and Biosimilars Market Forecast by Application (2018-2023)
        12.4.1 Global Biologics and Biosimilars Sales Forecast by Application (2018-2023)
        12.4.2 Global Biologics and Biosimilars Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
    13.1 Sales Channel
        13.1.1 Direct Marketing
        13.1.2 Indirect Marketing
        13.1.3 Marketing Channel Future Trend
    13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
    15.1 Methodology
    15.2 Data Source

	List of Tables and Figures

Figure Biologics and Biosimilars Picture
Table Product Specifications of Biologics and Biosimilars
Figure Global Sales Market Share of Biologics and Biosimilars by Types in 2017
Table Biologics and Biosimilars Types for Major Manufacturers
Figure Antibody Picture
Figure Hormone Picture
Figure Growth Factors Picture
Figure Other Picture
Figure Biologics and Biosimilars Sales Market Share by Applications in 2017
Figure Tumor Picture
Figure Diabetes Picture
Figure Cardiovascular Picture
Figure Hemophilia Picture
Figure Other Picture
Figure United States Biologics and Biosimilars Revenue (Value) and Growth Rate (2013-2023)
Figure Canada Biologics and Biosimilars Revenue (Value) and Growth Rate (2013-2023)
Figure Mexico Biologics and Biosimilars Revenue (Value) and Growth Rate (2013-2023)
Figure Germany Biologics and Biosimilars Revenue (Value) and Growth Rate (2013-2023)
Figure France Biologics and Biosimilars Revenue (Value) and Growth Rate (2013-2023)
Figure UK Biologics and Biosimilars Revenue (Value) and Growth Rate (2013-2023)
Figure Russia Biologics and Biosimilars Revenue (Value) and Growth Rate (2013-2023)
Figure Italy Biologics and Biosimilars Revenue (Value) and Growth Rate (2013-2023)
Figure China Biologics and Biosimilars Revenue (Value) and Growth Rate (2013-2023)
Figure Japan Biologics and Biosimilars Revenue (Value) and Growth Rate (2013-2023)
Figure Korea Biologics and Biosimilars Revenue (Value) and Growth Rate (2013-2023)
Figure India Biologics and Biosimilars Revenue (Value) and Growth Rate (2013-2023)
Figure Southeast Asia Biologics and Biosimilars Revenue (Value) and Growth Rate (2013-2023)
Figure Brazil Biologics and Biosimilars Revenue (Value) and Growth Rate (2013-2023)
Figure Egypt Biologics and Biosimilars Revenue (Value) and Growth Rate (2013-2023)
Figure Saudi Arabia Biologics and Biosimilars Revenue (Value) and Growth Rate (2013-2023)
Figure South Africa Biologics and Biosimilars Revenue (Value) and Growth Rate (2013-2023)
Figure Nigeria Biologics and Biosimilars Revenue (Value) and Growth Rate (2013-2023)
Table Roche Basic Information, Manufacturing Base and Competitors
Table Roche Biologics and Biosimilars Type and Applications
Table Roche Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Amgen Basic Information, Manufacturing Base and Competitors
Table Amgen Biologics and Biosimilars Type and Applications
Table Amgen Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table AbbVie Basic Information, Manufacturing Base and Competitors
Table AbbVie Biologics and Biosimilars Type and Applications
Table AbbVie Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Sanofi-Aventis Basic Information, Manufacturing Base and Competitors
Table Sanofi-Aventis Biologics and Biosimilars Type and Applications
Table Sanofi-Aventis Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table Johnson & Johnson Biologics and Biosimilars Type and Applications
Table Johnson & Johnson Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Pfizer Basic Information, Manufacturing Base and Competitors
Table Pfizer Biologics and Biosimilars Type and Applications
Table Pfizer Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Novo Nordisk Basic Information, Manufacturing Base and Competitors
Table Novo Nordisk Biologics and Biosimilars Type and Applications
Table Novo Nordisk Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Eli Lilly Basic Information, Manufacturing Base and Competitors
Table Eli Lilly Biologics and Biosimilars Type and Applications
Table Eli Lilly Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Novartis Basic Information, Manufacturing Base and Competitors
Table Novartis Biologics and Biosimilars Type and Applications
Table Novartis Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Merck Basic Information, Manufacturing Base and Competitors
Table Merck Biologics and Biosimilars Type and Applications
Table Merck Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table 3sbio Basic Information, Manufacturing Base and Competitors
Table 3sbio Biologics and Biosimilars Type and Applications
Table 3sbio Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Changchun High Tech Basic Information, Manufacturing Base and Competitors
Table Changchun High Tech Biologics and Biosimilars Type and Applications
Table Changchun High Tech Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table CP Guojian Basic Information, Manufacturing Base and Competitors
Table CP Guojian Biologics and Biosimilars Type and Applications
Table CP Guojian Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Biotech Basic Information, Manufacturing Base and Competitors
Table Biotech Biologics and Biosimilars Type and Applications
Table Biotech Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Gelgen Basic Information, Manufacturing Base and Competitors
Table Gelgen Biologics and Biosimilars Type and Applications
Table Gelgen Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Innovent Basic Information, Manufacturing Base and Competitors
Table Innovent Biologics and Biosimilars Type and Applications
Table Innovent Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Dong Bao Basic Information, Manufacturing Base and Competitors
Table Dong Bao Biologics and Biosimilars Type and Applications
Table Dong Bao Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Ganlee Basic Information, Manufacturing Base and Competitors
Table Ganlee Biologics and Biosimilars Type and Applications
Table Ganlee Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table United Laboratories Basic Information, Manufacturing Base and Competitors
Table United Laboratories Biologics and Biosimilars Type and Applications
Table United Laboratories Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Others Basic Information, Manufacturing Base and Competitors
Table Others Biologics and Biosimilars Type and Applications
Table Others Biologics and Biosimilars Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Global Biologics and Biosimilars Sales by Manufacturer (2016-2017)
Figure Global Biologics and Biosimilars Sales Market Share by Manufacturer in 2016
Figure Global Biologics and Biosimilars Sales Market Share by Manufacturer in 2017
Table Global Biologics and Biosimilars Revenue by Manufacturer (2016-2017)
Figure Global Biologics and Biosimilars Revenue Market Share by Manufacturer in 2016
Figure Global Biologics and Biosimilars Revenue Market Share by Manufacturer in 2017
Figure Top 3 Biologics and Biosimilars Manufacturer (Revenue) Market Share in 2017
Figure Top 6 Biologics and Biosimilars Manufacturer (Revenue) Market Share in 2017
Figure Global Biologics and Biosimilars Sales and Growth Rate (2013-2018)
Figure Global Biologics and Biosimilars Revenue and Growth Rate (2013-2018)
Table Global Biologics and Biosimilars Sales by Regions (2013-2018)
Table Global Biologics and Biosimilars Sales Market Share by Regions (2013-2018)
Table Global Biologics and Biosimilars Revenue by Regions (2013-2018)
Figure Global Biologics and Biosimilars Revenue Market Share by Regions in 2013
Figure Global Biologics and Biosimilars Revenue Market Share by Regions in 2017
Figure North America Biologics and Biosimilars Sales and Growth Rate (2013-2018)
Figure Europe Biologics and Biosimilars Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Biologics and Biosimilars Sales and Growth Rate (2013-2018)
Figure South America Biologics and Biosimilars Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Biologics and Biosimilars Sales and Growth Rate (2013-2018)
Figure North America Biologics and Biosimilars Revenue and Growth Rate (2013-2018)
Table North America Biologics and Biosimilars Sales by Countries (2013-2018)
Table North America Biologics and Biosimilars Sales Market Share by Countries (2013-2018)
Figure North America Biologics and Biosimilars Sales Market Share by Countries in 2013
Figure North America Biologics and Biosimilars Sales Market Share by Countries in 2017
Table North America Biologics and Biosimilars Revenue by Countries (2013-2018)
Table North America Biologics and Biosimilars Revenue Market Share by Countries (2013-2018)
Figure North America Biologics and Biosimilars Revenue Market Share by Countries in 2013
Figure North America Biologics and Biosimilars Revenue Market Share by Countries in 2017
Figure United States Biologics and Biosimilars Sales and Growth Rate (2013-2018)
Figure Canada Biologics and Biosimilars Sales and Growth Rate (2013-2018)
Figure Mexico Biologics and Biosimilars Sales and Growth Rate (2013-2018)
Figure Europe Biologics and Biosimilars Revenue and Growth Rate (2013-2018)
Table Europe Biologics and Biosimilars Sales by Countries (2013-2018)
Table Europe Biologics and Biosimilars Sales Market Share by Countries (2013-2018)
Table Europe Biologics and Biosimilars Revenue by Countries (2013-2018)
Figure Europe Biologics and Biosimilars Revenue Market Share by Countries in 2016
Figure Europe Biologics and Biosimilars Revenue Market Share by Countries in 2017
Figure Germany Biologics and Biosimilars Sales and Growth Rate (2013-2018)
Figure UK Biologics and Biosimilars Sales and Growth Rate (2013-2018)
Figure France Biologics and Biosimilars Sales and Growth Rate (2013-2018)
Figure Russia Biologics and Biosimilars Sales and Growth Rate (2013-2018)
Figure Italy Biologics and Biosimilars Sales and Growth Rate (2013-2018)
Figure Asia-Pacific Biologics and Biosimilars Revenue and Growth Rate (2013-2018)
Table Asia-Pacific Biologics and Biosimilars Sales by Countries (2013-2018)
Table Asia-Pacific Biologics and Biosimilars Sales Market Share by Countries (2013-2018)
Figure Asia-Pacific Biologics and Biosimilars Sales Market Share by Countries 2017
Table Asia-Pacific Biologics and Biosimilars Revenue by Countries (2013-2018)
Figure Asia-Pacific Biologics and Biosimilars Revenue Market Share by Countries 2017
Figure China Biologics and Biosimilars Sales and Growth Rate (2013-2018)
Figure Japan Biologics and Biosimilars Sales and Growth Rate (2013-2018)
Figure Korea Biologics and Biosimilars Sales and Growth Rate (2013-2018)
Figure India Biologics and Biosimilars Sales and Growth Rate (2013-2018)
Figure Southeast Asia Biologics and Biosimilars Sales and Growth Rate (2013-2018)
Figure South America Biologics and Biosimilars Revenue and Growth Rate (2013-2018)
Table South America Biologics and Biosimilars Sales by Countries (2013-2018)
Table South America Biologics and Biosimilars Sales Market Share by Countries (2013-2018)
Figure South America Biologics and Biosimilars Sales Market Share by Countries in 2017
Table South America Biologics and Biosimilars Revenue by Countries (2013-2018)
Table South America Biologics and Biosimilars Revenue Market Share by Countries (2013-2018)
Figure South America Biologics and Biosimilars Revenue Market Share by Countries in 2017
Figure Brazil Biologics and Biosimilars Sales and Growth Rate (2013-2018)
Figure Argentina Biologics and Biosimilars Sales and Growth Rate (2013-2018)
Figure Colombia Biologics and Biosimilars Sales and Growth Rate (2013-2018)
Figure Middle East and Africa Biologics and Biosimilars Revenue and Growth Rate (2013-2018)
Table Middle East and Africa Biologics and Biosimilars Sales by Countries (2013-2018)
Table Middle East and Africa Biologics and Biosimilars Sales Market Share by Countries (2013-2018)
Figure Middle East and Africa Biologics and Biosimilars Sales Market Share by Countries in 2017
Table Middle East and Africa Biologics and Biosimilars Revenue by Countries (2013-2018)
Table Middle East and Africa Biologics and Biosimilars Revenue Market Share by Countries (2013-2018)
Figure Middle East and Africa Biologics and Biosimilars Revenue Market Share by Countries in 2013
Figure Middle East and Africa Biologics and Biosimilars Revenue Market Share by Countries in 2017
Figure Saudi Arabia Biologics and Biosimilars Sales and Growth Rate (2013-2018)
Figure UAE Biologics and Biosimilars Sales and Growth Rate (2013-2018)
Figure Egypt Biologics and Biosimilars Sales and Growth Rate (2013-2018)
Figure Nigeria Biologics and Biosimilars Sales and Growth Rate (2013-2018)
Figure South Africa Biologics and Biosimilars Sales and Growth Rate (2013-2018)
Table Global Biologics and Biosimilars Sales by Type (2013-2018)
Table Global Biologics and Biosimilars Sales Share by Type (2013-2018)
Table Global Biologics and Biosimilars Revenue by Type (2013-2018)
Table Global Biologics and Biosimilars Revenue Share by Type (2013-2018)
Figure Global Antibody Sales Growth (2013-2018)
Figure Global Antibody Price (2013-2018)
Figure Global Hormone Sales Growth (2013-2018)
Figure Global Hormone Price (2013-2018)
Figure Global Growth Factors Sales Growth (2013-2018)
Figure Global Growth Factors Price (2013-2018)
Figure Global Other Sales Growth (2013-2018)
Figure Global Other Price (2013-2018)
Table Global Biologics and Biosimilars Sales by Application (2013-2018)
Table Global Biologics and Biosimilars Sales Share by Application (2013-2018)
Figure Global Diabetes Sales Growth (2013-2018)
Figure Global Cardiovascular Sales Growth (2013-2018)
Figure Global Hemophilia Sales Growth (2013-2018)
Figure Global Other Sales Growth (2013-2018)
Figure Global Biologics and Biosimilars Sales, Revenue and Growth Rate (2018-2023)
Table Global Biologics and Biosimilars Sales Forecast by Regions (2018-2023)
Table Global Biologics and Biosimilars Market Share Forecast by Regions (2018-2023)
Figure North America Sales Biologics and Biosimilars Market Forecast (2018-2023)
Figure Europe Sales Biologics and Biosimilars Market Forecast (2018-2023)
Figure Asia-Pacific Sales Biologics and Biosimilars Market Forecast (2018-2023)
Figure South America Sales Biologics and Biosimilars Market Forecast (2018-2023)
Figure Middle East and Africa Sales Biologics and Biosimilars Market Forecast (2018-2023)
Table Global Biologics and Biosimilars Sales Forecast by Type (2018-2023)
Table Global Biologics and Biosimilars Market Share Forecast by Type (2018-2023)
Table Global Biologics and Biosimilars Sales Forecast by Application (2018-2023)
Table Global Biologics and Biosimilars Market Share Forecast by Application (2018-2023)
Table Distributors/Traders/ Dealers List

Related Reports

North America Trauma Fixation Market Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025

North America trauma fixation market is projected to register a healthy CAGR of 7.0 % in the forecast period of 2018 to 2025. The new market report contains data for historic years 2017, the base year ...read more

Middle East and Africa Trauma Fixation Market Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025

Middle East & Africa trauma fixation market is projected to register a healthy CAGR of 5.9% in the forecast period 2018 to 2025. The new market report contains data for historic years 2017, the base y ...read more

Global Trauma Fixation Market Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025

Global trauma fixation market is projected to register a healthy CAGR of 6.9% in the forecast period 2018 to 2025. The new market report contains data for historic years 2017, the base year of calcula ...read more

Europe Trauma Fixation Market Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025

Europe trauma fixation market is projected to register a healthy CAGR of 6.5 % in the forecast period 2018 to 2025. The new market report contains data for historic years 2017, the base year of calcul ...read more

Asia-Pacific Trauma Fixation Market Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025

Asia Pacific trauma fixation market is projected to register a healthy CAGR of 7.5 % in the forecast period 2018 to 2025. The new market report contains data for historic years 2017, the base year of ...read more

Choose License Type

Single User - This is a single user license, allowing one specific user access to the product.

Multi User - This is a 1-5 user licence, allowing up to five users have access to the product.

Enterprise User - This is an enterprise license, allowing all employees within your organisation access to the product. The report will be emailed to you.

Why Choose Us

  • Lowest Price Guarantee
  • We offer the lowest prices for the listed reports
  • Data Security
  • Your data is safe and secure
  • Vast Report Database
  • We have more than 2 Million reports in our database
  • Client Focused
  • Personalized updates and 24*7 support
  • Trusted Source and Quality
  • We only work with reputable partners providing high quality research and support
  • Market Segmentation
  • We provide alternative views of the market to help you identify where the real opportunities lie
  • Bulk Discounts
  • We offer great discounts on purchase of multiple reports

How To Reach Us

Reach out to our most senior Sales Professional- Jay Matthews
   +1 513 549 5911 (US)
          +44 203 318 2846 (UK)
   sales@reportsmonitor.com

Our Clients

Testimonials

Well structured, the insights they shared with us were very helpful and reliable. Their timely assistance make their services invaluable to us. I would highly recommend them and would definitely use them again in the future if needed.
-VP of a Automotive division in Germany

The report sent to us was on the point, and its information was quite extensive, well structured, and well researched. More importantly what we valued was your response time and professionalism. As a leading global consulting firm, our clients expect high quality deliverables in short periods of time, so a reliable research partner is essential. For the price that you have charged the quality of your services were exceptional. We look forward to continue our relationship with your team on future engagements
-Product Manager at US based Manufacturer

Coherent, high-quality, thoroughly-researched reports. We received a very quick response to all our queries which eventually expedited the entire process
--Marketing Manager at a pharma company in Belgium

Enquire Before Buying

Need to ask a quick question before buying? Please fill out this short form:

Our Features

Wide Network of Publishers

Wide Network of Publishers

Access to over 1M+ market research reports

Trusted by the Best

Trusted by the Best

50+ Clients in Fortune 500

Competitive Pricing

Competitive Pricing

Our regular promotional offers and discounts make us the most economic seller of market reports

Safe and Secure

Safe and Secure

Your payment details are protected by us.